Leuprolide Acetate injections are usually given once every 28 days and are not recommended to be given earlier or later. Leuprolide acetate injection is a gonadotropin-releasing hormone receptor agonist, for patients with endometriosis and adenomyosis, after injection, it inhibits the function of the female gonadal axis through competitive binding of gonadotropin-releasing hormone receptors and thus has a certain therapeutic effect on the disease, and incorrect timing of intramuscular injection will affect the hormone secretion of the body, which will in turn affect the therapeutic effect. Because this product will inhibit the function of the female reproductive axis, so some women may have hot flashes, night sweats, insomnia, loss of libido and other menopausal syndrome-like clinical manifestations, at the same time for the product allergy, pregnancy and lactation, vaginal bleeding of unknown reasons should be prohibited. For patients with endometriosis and adenomyosis, it is recommended that they go to the gynecology department of a regular hospital and choose the appropriate treatment under the guidance of the doctor, rather than blindly using drugs.